ALT-007
ALT-007 is an orally active serine palmitoyltransferase (SPT) inhibitor that selectively reduces the levels of toxic very-long-chain deoxysphingolipids to enhance protein homeostasis. ALT-007 restores aging-related loss of muscle mass in a mouse model of sarcopenia. ALT-007 enhances protein homeostasis in both mouse and C. elegans models of aging and disease. ALT-007 can be used for age-related neuromuscular diseases research[1].
Product Specifications
CAS Number
2035010-37-6
UNSPSC
12352005
Target
Acyltransferase; Ceramidase
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Purity
99.81
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(NC1C(N(C(C)C)N=C2)=C2N(C(C3=CN=C(OC)C(OC)=C3)=O)CC1)C4=CC=CC=C4OC(F)(F)F
Molecular Formula
C25H26F3N5O5
Molecular Weight
533.50
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
RPGR (X-linked retinitis pigmentosa GTPase Regulator, RPGR, RP3, XLRP3, CRD, COD1, PCDX, RP15, orf15, CORDX1, ) discontinued
RPGR (X-linked retinitis pigmentosa GTPase Regulator, RPGR, RP3, XLRP3, CRD, COD1, PCDX, RP15, orf15, CORDX1, ) discontinued
MTA1 (Metastasis Associated 1) (MaxLight 405)